Unlocking the full potential of artificial intelligence requires these stakeholders to ensure their data are accessible and secure.
Inger Ødum Nielsen, Vanessa de Langsdorff, and John April
Advertisement
Articles by Inger Ødum Nielsen, Vanessa de Langsdorff, and John April
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
NEJM Retracts Tavneos Trial Paper as FDA, EMA Both Move to Pull Amgen Drug From Market
2
Real-Time Clinical Trials: What the FDA's Push Toward Continuous Oversight Means for Sponsors
3
ACT Brief: DIA Leadership and Infrastructure Priorities, Real-Time Data Review Readiness, and CLL Treatment Expansion
4
Built-In, Not Bolted On: Why Clinical Data Security Has to Be a Design Principle
5